Validation of a prognostic nomogram in patients undergoing resection for pancreatic ductal adenocarcinoma in a UK tertiary referral centre

HPB

Volumn 10, Issue 6, 2008, Pages 501-505

  Clark, E J ^a   Taylor, M A ^a   Connor, S ^a   O'Neill, R ^a   Brennan, M F ^b   Garden, O J ^a   Parks, R W ^a  

^a ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Nomogram; Pancreatic adenocarcinoma; Prognosis

Indexed keywords

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NOMOGRAM; PANCREAS ADENOCARCINOMA; PANCREAS RESECTION; PANCREATICODUODENECTOMY; PROGNOSIS; RETROSPECTIVE STUDY; SCORING SYSTEM; SPLENECTOMY; STATISTICAL ANALYSIS; UNITED KINGDOM; VALIDATION PROCESS;

EID: 57049140598     PISSN: 1365182X     EISSN: 14772574     Source Type: Journal    
DOI: 10.1080/13651820802356606     Document Type: Article

References (31)

1. Conlon, KC, Klimstra, DS and Brennan, MF. (1996) Long-term survival after curative resection for pancreatic ductal adenocarcinoma. Clinicopathologic analysis of 5-year survivors. Ann Surg, 223:3, pp. 273-279.
2. Cameron, JL, Crist, DW, Sitzmann, JV, Hruban, RH, Boitnott, JK, Seidler, AJ and Coleman, J. (1991) Factors influencing survival after pancreaticoduodenectomy for pancreatic cancer. Am J Surg, 161:1, pp. 120-124.
3. Geer, RJ and Brennan, MF. (1993) Prognostic indicators for survival after resection of pancreatic adenocarcinoma. Am J Surg, 165:1, pp. 68-72.
4. Yeo, CJ, Cameron, JL, Lillemoe, KD, Sitzmann, JV, Hruban, RH Goodman, SN et al. (1995) Pancreaticoduodenectomy for cancer of the head of the pancreas. 201 patients. Ann Surg, 221:6, pp. 721-731.
5. Sohn, TA, Yeo, CJ, Cameron, JL, Koniaris, L., Kaushal, S. Abrams, RA et al. (2000) Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators. J Gastrointest Surg, 4:6, pp. 567-579.
6. Yeo, CJ, Abrams, RA, Grochow, LB, Sohn, TA, Ord, SE Hruban, RH et al. (1997) Pancreaticoduodenectomy for pancreatic adenocarcinoma: postoperative adjuvant chemoradiation improves survival. A prospective, single-institution experience. Ann Surg, 225:5, pp. 621-633.
7. Kuhlmann, KF, de Castro, SM, Wesseling, JG, ten Kate, FJ, Offerhaus, GJ Busch, OR et al. (2004) Surgical treatment of pancreatic adenocarcinoma; actual survival and prognostic factors in 343 patients. Eur J Cancer, 40:4, pp. 549-558.
8. Nagakawa, T., Nagamori, M., Futakami, F., Tsukioka, Y., Kayahara, M. Ohta, T. et al. (1996) Results of extensive surgery for pancreatic carcinoma. Cancer, 77:4, pp. 640-645.
9. Nagakawa, T., Konishi, I., Ueno, K., Ohta, T., Kayahara, M. and Miyazaki, I. (1998) Extended radical pancreatectomy for carcinoma of the head of the pancreas. Hepatogastroenterology, 45:21, pp. 849-854.
10. Cameron, JL, Pitt, HA, Yeo, CJ, Lillemoe, KD, Kaufman, HS and Coleman, J. (1993) One hundred and forty-five consecutive pancreaticoduodenectomies without mortality. Ann Surg, 217:5, pp. 430-435.
11. Schniewind, B., Bestmann, B., Henne-Bruns, D., Faendrich, F., Kremer, B. and Kuechler, T. (2006) Quality of life after pancreaticoduodenectomy for ductal adenocarcinoma of the pancreatic head. Br J Surg, 93:9, pp. 1099-1107.
12. Nieveen van Dijkum, EJ, Kuhlmann, KF, Terwee, CB, Obertop, H., de Haes, JC and Gouma, DJ. (2005) Quality of life after curative or palliative surgical treatment of pancreatic and periampullary carcinoma. Br J Surg, 92:4, pp. 471-477.
13. Smaletz, O., Scher, HI, Small, EJ, Verbel, DA, McMillan, A. Regan, K. et al. (2002) Nomogram for overall survival of patients with progressive metastatic prostate cancer after castration. J Clin Oncol, 20:19, pp. 3972-3982.
14. Kattan, MW, Leung, DH and Brennan, MF. (2002) Postoperative nomogram for 12-year sarcoma-specific death. J Clin Oncol, 20:3, pp. 791-796.
15. Kattan, MW, Karpeh, MS, Mazumdar, M. and Brennan, MF. (2003) Postoperative nomogram for disease-specific survival after an R0 resection for gastric carcinoma. J Clin Oncol, 21:19, pp. 3647-3650.
16. Hoang, T., Xu, R., Schiller, JH, Bonomi, P. and Johnson, DH. (2005) Clinical model to predict survival in chemonaive patients with advanced non-small-cell lung cancer treated with third-generation chemotherapy regimens based on eastern cooperative oncology group data. J Clin Oncol, 23:1, pp. 175-183.
17. Massacesi, C., Norman, A., Price, T., Hill, M., Ross, P. and Cunningham, D. (2000) A clinical nomogram for predicting long-term survival in advanced colorectal cancer. Eur J Cancer, 36:16, pp. 2044-2052.
18. Brennan, MF, Kattan, MW, Klimstra, D. and Conlon, K. (2004) Prognostic nomogram for patients undergoing resection for adenocarcinoma of the pancreas. Ann Surg, 240:2, pp. 293-298.
19. Royal College of Pathologists Working Group on Cancer Services (2002) Minimum dataset for the histopathological reporting on pancreatic, ampulla of Vater and bile duct carcinoma, Royal College of Pathologists, London
20. Luttges, J., Vogel, I., Menke, M., Henne-Bruns, D., Kremer, B. and Kloppel, G. (1998) The retroperitoneal resection margin and vessel involvement are important factors determining survival after pancreaticoduodenectomy for ductal adenocarcinoma of the head of the pancreas. Virchows Arch, 433:3, pp. 237-242.
21. Luttges, J., Zamboni, G. and Kloppel, G. (1999) Recommendation for the examination of pancreaticoduodenectomy specimens removed from patients with carcinoma of the exocrine pancreas. A proposal for a standardised pathological staging of pancreaticoduodenectomy specimens including a checklist. Dig Surg, 16:4, pp. 291-296.
22. Tseng, JF, Raut, CP, Lee, JE, Pisters, PW, Vauthey, JN Abdalla, EK et al. (2004) Pancreaticoduodenectomy with vascular resection: Margin status and survival duration. J Gastrointest Surg, 8:8, pp. 935-949.
23. Albores-Saavedra, J., Heffess, C., Hruban, RH, Klimstra, D. and Longnecker, D. (1999) Recommendations for the reporting of pancreatic specimens containing malignant tumors. The Association of Directors of Anatomic and Surgical Pathology. Am J Clin Pathol, 111:3, pp. 304-307.
24. Greene, FL, Page, DL, Fleming, ID, Fritz, A., Balch, CM, Haller, DG and Morrow, M. (2002) AJCC Cancer Staging Manual, Springer-Verlag, New York
25. Staley, CA, Cleary, KR, Abbruzzese, JL, Lee, JE, Ames, FC, Fenoglio, CJ and Evans, DB. (1996) The need for standardised pathologic staging of pancreaticoduodenectomy specimens. Pancreas, 12:4, pp. 373-380.
26. Pedrazzoli, S., Beger, HG, Obertop, H., Andren-Sandberg, A., Fernandez-Cruz, L. Henne-Bruns, D. et al. (1999) A surgical and pathological based classification of resective treatment of pancreatic cancer. Summary of an international workshop on surgical procedures in pancreatic cancer. Dig Surg, 16:4, pp. 337-345.
27. Verbeke, CS, Leitch, D., Menon, KV, McMahon, MJ, Guillou, PJ and Anthoney, A. (2006) Redefining the R1 resection in pancreatic cancer. Br J Surg, 93:10, pp. 1232-1237.
28. Neoptolemos, JP, Dunn, JA, Stocken, DD, Almond, J., Link, K. Beger, H. et al. (2001) Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: A randomised controlled trial. Lancet, 358:9293, pp. 1576-1585.
29. Kalser, MH and Ellenberg, SS. (1985) Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection. Arch Surg, 120:8, pp. 899-903.
30. Gastrointestinal Tumor Study Group (1987) Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer. Cancer, 59:12, pp. 2006-2010.
31. Ferrone, CR, Kattan, MW, Tomlinson, JS, Thayer, SP, Brennan, MF and Warshaw, AL. (2005) Validation of a postresection pancreatic adenocarcinoma nomogram for disease-specific survival. J Clin Oncol, 23:30, pp. 7529-7535.